A M J van Wegberg1, A MacDonald2, D Abeln3, T S Hagedorn4, E Lange5, F Trefz6, D van Vliet1, F J van Spronsen7. 1. Department of Metabolic Diseases, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, 9713 GZ, Groningen, The Netherlands. 2. Dietetic Department, Birmingham Children's Hospital, Birmingham, B4 6NH, UK. 3. Dutch Society for PKU, Tiel, The Netherlands. 4. Deutsche Interessengemeinschaft Phenylketonurie, Fürth, Germany. 5. National Society for Phenylketonuria United Kingdom, Preston, UK. 6. University Children's Hospital, Dietmar Hopp Metabolic Centre, 69120, Heidelberg, Germany. 7. Department of Metabolic Diseases, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, 9713 GZ, Groningen, The Netherlands. f.j.van.spronsen@umcg.nl.
Abstract
BACKGROUND: In the Netherlands (NL) the government assigned 2 hospitals as centres of expertise (CE) for Phenylketonuria (PKU), while in the United Kingdom (UK) and Germany no centres are assigned specifically as PKU CE's. METHODS: To identify expectations of patients/caregivers with PKU of CEs, a web-based survey was distributed through the national Phenylketonuria societies of Germany, NL and UK. RESULTS: In total, 105 responded (43 patients, 56 parents, 4 grandparents, 2 other) of whom 59 were from NL, 33 from UK and 13 from Germany. All participants (n = 105) agreed that patients and/or practitioners would benefit from CEs. The frequency patients would want to visit a CE, when not treated in a CE (n = 83) varied: every hospital visit (24%, n = 20), annual or bi-annual (45%, n = 37), at defined patient ages (6%, n = 5), one visit only (22%, n = 18), or never (4%, n = 3). Distance was reported as a major barrier (42%, n = 35). 78% (n = 65) expected CE physicians and dieticians to have a higher level of knowledge than in non-CE centres. For participants already treated in a CE (n = 68), 66% requested a more extensive annual or bi-annual review. In general, psychology review and neuropsychologist assessment were identified as necessary by approximately half of the 105 participants. In addition, 66% (n = 68) expected a strong collaboration with patient associations. CONCLUSION: In this small study, most participants expected that assigning CEs will change the structure of and delivery of Phenylketonuria care.
BACKGROUND: In the Netherlands (NL) the government assigned 2 hospitals as centres of expertise (CE) for Phenylketonuria (PKU), while in the United Kingdom (UK) and Germany no centres are assigned specifically as PKU CE's. METHODS: To identify expectations of patients/caregivers with PKU of CEs, a web-based survey was distributed through the national Phenylketonuria societies of Germany, NL and UK. RESULTS: In total, 105 responded (43 patients, 56 parents, 4 grandparents, 2 other) of whom 59 were from NL, 33 from UK and 13 from Germany. All participants (n = 105) agreed that patients and/or practitioners would benefit from CEs. The frequency patients would want to visit a CE, when not treated in a CE (n = 83) varied: every hospital visit (24%, n = 20), annual or bi-annual (45%, n = 37), at defined patient ages (6%, n = 5), one visit only (22%, n = 18), or never (4%, n = 3). Distance was reported as a major barrier (42%, n = 35). 78% (n = 65) expected CE physicians and dieticians to have a higher level of knowledge than in non-CE centres. For participants already treated in a CE (n = 68), 66% requested a more extensive annual or bi-annual review. In general, psychology review and neuropsychologist assessment were identified as necessary by approximately half of the 105 participants. In addition, 66% (n = 68) expected a strong collaboration with patient associations. CONCLUSION: In this small study, most participants expected that assigning CEs will change the structure of and delivery of Phenylketonuria care.
Entities:
Keywords:
Centre of expertise; European reference network; Patients view; Phenylketonuria
Authors: Francjan J van Spronsen; Annemiek Mj van Wegberg; Kirsten Ahring; Amaya Bélanger-Quintana; Nenad Blau; Annet M Bosch; Alberto Burlina; Jaime Campistol; Francois Feillet; Maria Giżewska; Stephan C Huijbregts; Shauna Kearney; Vincenzo Leuzzi; Francois Maillot; Ania C Muntau; Fritz K Trefz; Margreet van Rijn; John H Walter; Anita MacDonald Journal: Lancet Diabetes Endocrinol Date: 2017-01-10 Impact factor: 32.069
Authors: Rianne Jahja; Stephan C J Huijbregts; Leo M J de Sonneville; Jaap J van der Meere; Francjan J van Spronsen Journal: J Pediatr Date: 2014-01-30 Impact factor: 4.406
Authors: Carol S Camfield; Marissa Joseph; Teresa Hurley; Karen Campbell; Susan Sanderson; Peter R Camfield Journal: J Pediatr Date: 2004-07 Impact factor: 4.406
Authors: Kimia Honarmand; Sabhyata Malik; Conor Wild; Laura E Gonzalez-Lara; Christopher W McIntyre; Adrian M Owen; Marat Slessarev Journal: PLoS One Date: 2019-04-12 Impact factor: 3.240
Authors: Eddie Donaghy; Helen Atherton; Victoria Hammersley; Hannah McNeilly; Annemieke Bikker; Lucy Robbins; John Campbell; Brian McKinstry Journal: Br J Gen Pract Date: 2019-08-29 Impact factor: 5.386